NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
151-165 of 394

The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiersThe Complexities of DMD: Optimizing Multidisciplinary Care

Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiersReducing the Burden of gMG with a Novel B-Cell Therapy

Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiersInvestigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT

Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiersExploring IGF1R as a New Therapeutic Target in Myasthenia Gravis

Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiersImproving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations

Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
NeuroFrontiersInflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
- advertisement

Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiersHarnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention

Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiersGut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers

Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiersStudying Cortical Lesions in MS: Future Research Directions

Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiersReducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study

Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiersUnraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS

mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiersmIDH Gliomas Explained: Characteristics and Management Strategies
- advertisement

From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiersFrom Diagnosis to Treatment: Challenges in Glioblastoma Care

Climate Change in the Clinic: Examining Neurological Impacts
NeuroFrontiersClimate Change in the Clinic: Examining Neurological Impacts

Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiersVorasidenib and mIDH Gliomas: Reviewing the Efficacy Data






























